BioPower Operations Corporation (BOPO)

BioPower Operations Cash Flow Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2015
Period Ending	May 31, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2015
Net Income	-6.17	-0.79	-0.44	-0.13	-0.13	-2.21
Depreciation & Amortization	-	-	-	-	-	0.01
Other Amortization	0.22	0.15	-	-	-	0.22
Loss (Gain) From Sale of Assets	-	-	-	-	-	0
Stock-Based Compensation	4.42	-	0	-	-	0.08
Other Operating Activities	-0	-0.07	-	-	-	0.01
Change in Accounts Receivable	-	-0	-	-	-	-
Change in Inventory	0	-0.01	-	-	-	-
Change in Accounts Payable	1.2	0.65	0.23	0.13	0.13	1.62
Change in Unearned Revenue	0.38	0.38	-	-	-	-
Change in Other Net Operating Assets	0.08	-	-	-	-	-0.01
Operating Cash Flow	0.13	0.31	-0.2	-	-	-0.29
Capital Expenditures	-	-	-	-	-	-0.01
Investing Cash Flow	-	-	-	-	-	-0.01
Short-Term Debt Issued	-	0.22	-	-	-	0.22
Total Debt Issued	0.22	0.22	-	-	-	0.22
Short-Term Debt Repaid	-	-1	-	-	-	-0.01
Total Debt Repaid	-1	-1	-	-	-	-0.01
Net Debt Issued (Repaid)	-0.78	-0.78	-	-	-	0.21
Issuance of Common Stock	0.13	0.37	0.3	-	-	0.08
Financing Cash Flow	-0.65	-0.4	0.3	-	-	0.28
Net Cash Flow	-0.52	-0.1	0.1	-	-	-0.01
Free Cash Flow	0.13	0.31	-0.2	-	-	-0.3
Free Cash Flow Margin	102.99%	53.54%	-116.59%	-	-	-2201.84%
Free Cash Flow Per Share	0.00	0.01	-0.01	-	-	-0.01
Levered Free Cash Flow	2.76	0.89	-	-	-	0.57
Unlevered Free Cash Flow	2.73	0.91	-	-	-	0.51
Change in Net Working Capital	-1.97	-1.28	-	-	-	-1.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.